AIDS News and Research

RSS

Health bodies to discuss steps to further reduce mother to child HIV transmission

Transmission of HIV to children before or at birth has dropped dramatically around the country in the last decade since the advent of powerful new therapies. That certainly is true for Florida, where each year, fewer than 10 babies are born with the disease despite the fact that more than 600 HIV-positive women each year, on average, give birth.

23 Jul 2010

Study identifies infection mechanism of disease-causing microbes

A study published in the July 23 issue of Cell identifies the mechanism used by several types of common, virulent microbes to infect plants and cause devastating blights. Microbes using this infection mechanism include fungi that are currently causing wheat rust epidemics in Africa and Asia, and a class of parasitic algae, called oomycetes, that resulted in the Irish potato blight of the 19th Century. These microbes remain an agricultural scourge today.

23 Jul 2010

NVCI, CSN and Workforce CONNECTIONS partner to launch ARRA funded nursing internship program

Nevada Cancer Institute (NVCI) is launching its Plus One Program, a paid nursing internship initiative to equip nursing graduates with advanced training to give them an edge in today's competitive nursing job market. After completing a paid one-year internship at NVCI, participants will become oncology nurses, a highly sought-after specialty. These specialized jobs have the potential to pay increased wages, provide excellent benefits and support articulated career ladders within the field of oncology.

23 Jul 2010

Early HAART during TB treatment prolongs survival of untreated HIV-infected adults: CAMELIA study

A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard.

23 Jul 2010

Boehringer Ingelheim's VERxVE study of nevirapine meets primary endpoint

New data were presented today at the 18th International AIDS Conference from the VERxVE study that show an investigational, once-daily extended-release (400 mg QD) formulation of nevirapine was non-inferior to twice-daily immediate release Viramune® (nevirapine) tablets (200 mg BID), both in combination with Truvada® (tenofovir and emtricitabine) tablets in treatment-naive HIV-1 infected patients through 48 weeks.

23 Jul 2010

Corporation for National and Community Service awards National AIDS Fund $3.6 million SIF grant

The National AIDS Fund announced today it is one of 11 organizations to receive the first-ever Social Innovation Fund grants, an initiative administered by the Corporation for National and Community Service. The $3.6 million SIF grant will enable NAF to expand the scope of its Access to Care initiative in support of innovative public-private partnerships to improve individual health outcomes and strengthen local services systems, connecting economically and socially marginalized individuals living with HIV to high quality supportive services and health care.

23 Jul 2010

Pfizer announces unrestricted access to patient assessment aids for mental disorders

As part of its commitment to improving the quality of patient care, Pfizer today announced that it will make available assessment scales used by physicians and others in the healthcare community to support the evaluation and diagnosis of patients suffering from certain mental disorders.

23 Jul 2010

AIDS 2010 studies, releases: Criminalization, discrimination of high-risk groups; Test-and-treat; UNAIDS launches HIV prevention commission

The criminalization of men who have sex with men (MSM) and transgender people in Asia is holding back efforts to contain HIV/AIDS in the region, according to a report presented Wednesday by the U.N. Development Program (UNDP) and Asia Pacific Coalition on Male Sexual Health at the International AIDS Conference-AIDS 2010, VOA News reports. The report "linked the criminalization of homosexual behavior to an increase in the infection rate of HIV and AIDS in Asia," the news service writes (Dewan, 7/21).

23 Jul 2010

AIDS 2010: Halving HIV/TB co-infection deaths; Financial transaction tax discussed, and more

UNAIDS and the Stop TB Partnership joined together on Thursday at the International AIDS Conference-AIDS 2010 in Vienna, Austria, with the goal of preventing 200,000 deaths annually from HIV and tuberculosis co-infection, Agence France-Presse reports. TB is the number one killer of people living with HIV/AIDS (Ingham, 7/22).

23 Jul 2010

New HIV drug on the block

Johnson and Johnson’s experimental HIV drug rilpivirine or TMC278, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is being developed for use in combination therapy for treating the human immunodeficiency virus (HIV) that causes AIDS. Two clinical trials with the drug has shown that although its effectiveness was same as the existing anti-HIV drugs, its side effects were fewer. On the flip side nearly twice as many patients failed to respond to treatment with the new drug.

22 Jul 2010

Tibotec reports Phase 3 trial results of TMC278 vs. EFV in treatment-naive HIV-1-infected adults

Tibotec Pharmaceuticals announced today results from two pivotal Phase 3, double-blind, randomized clinical trials comparing the efficacy, safety and tolerability of its investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC278 (rilpivirine) versus efavirenz (EFV), each administered once daily with a nucleoside/nucleotide background regimen in treatment-naive, HIV-1-infected adults.

22 Jul 2010

Towards a cure: HIV reservoirs and strategies to control them

Can HIV infection ever be cured? The prospect of efficiently controlling HIV persistence in infected persons was the topic of a high-level, two-day meeting of researchers gathered here on the eve of AIDS 2010, the biennial international conference of HIV researchers, funders, policy-makers and advocates.

22 Jul 2010

AHF calls upon Congress to immediately pass 'HIV/AIDS Saves Lives First Act of 2010'

AIDS Healthcare Foundation (AHF) will host a press teleconference on Thursday, July 22nd, at 1:00 PM Eastern (U.S.A.)/10:00 AM Pacific to urge the United States Congress to immediately pass the HIV/AIDS Saves Lives First Act of 2010. Introduced in the Senate Wednesday by Senator Tom Coburn, MD (R-OK), the bill seeks to save lives by making better use of existing resources for PEPFAR (the President's Emergency Plan for AIDS Relief), the US' successful global AIDS program.

22 Jul 2010

AHF hosts 'Test & Treat: Getting to 10 Million on ARVs' satellite session

As both cost containment of care and services and treatment-as-prevention gain greater prominence in the global fight against HIV/AIDS during the Vienna AIDS Conference, AIDS Healthcare Foundation (AHF), which currently provides AIDS medical care to more than 139,000 individuals in 23 countries worldwide, will host a satellite session today, July 21st, titled "Test and Treat: Getting to 10 Million on ARVs" (IAC Mini Room #5 at 6:30pm) preceded by a press conference (5pm, Media Center, Room PCR #2).

22 Jul 2010

Correlates of HIV stigma in HIV-positive women: Study

For some women, planning a family can be the first step towards one of life's most rewarding experiences. But a study led by Ryerson University researchers has found strong evidence that some HIV-positive women feel that they are being judged negatively by their healthcare providers for wanting to become moms and feel stigmatized by their physicians due to their medical condition.

22 Jul 2010

Adult circumcision proposed for possible HIV prevention in gay men

Adult circumcision has been proposed as a possible HIV prevention strategy for gay men, but a new study by the University of Pittsburgh Graduate School of Public Health presented at the XVIII International AIDS Conference suggests it would have a very small effect on reducing HIV incidence in the United States.

22 Jul 2010

New era of scientific innovation to drive novel ways of treating, preventing HIV

The unwillingness of the global AIDS community to accept the status quo is fuelling a new era of scientific innovation to drive novel ways of treating and preventing HIV, organizers of the XVIII International AIDS Conference taking place in Vienna, Austria said today. And, with millions of lives dependent on expanding access to antiretroviral treatment to all those clinically in need, researchers and clinicians are partnering in new ways to find the most effective and efficient methods to deliver treatment and strengthen health systems.

22 Jul 2010

Childhood experiences, psychosocial health problems increase risk of HIV in bisexual men

Gay and bisexual men enrolled in a long-term study of HIV who reported sexual abuse and social shaming in childhood experience psychosocial health problems later in life that could put them at greater risk for HIV, report University of Pittsburgh Graduate School of Public Health researchers at the XVIII International AIDS Conference.

22 Jul 2010

Current myths vs. realities in global AIDS funding

Activists at the International AIDS Conference in Vienna are charging developed and developing country governments with writing checques that bounce to the millions of people in need of lifesaving HIV treatment. Despite the gains in treatment numbers reported by WHO, the International Treatment Preparedness Coalition's (ITPC), latest report, Rationing Funds, Risking Lives, documents early warnings of the global pullback on AIDS commitment and funding.

22 Jul 2010

Study marks significant milestone for microbicide research field, HIV prevention

Today we congratulate the Centre for the AIDS Programme of Research in South Africa and the people of South Africa on the positive findings from the CAPRISA 004 microbicide study, which marks a significant milestone both for the microbicide research field and HIV prevention as a whole.

22 Jul 2010

AIDS News and Research

Health bodies to discuss steps to further reduce mother to child HIV transmission

Study identifies infection mechanism of disease-causing microbes

NVCI, CSN and Workforce CONNECTIONS partner to launch ARRA funded nursing internship program

Early HAART during TB treatment prolongs survival of untreated HIV-infected adults: CAMELIA study

Boehringer Ingelheim's VERxVE study of nevirapine meets primary endpoint

Corporation for National and Community Service awards National AIDS Fund $3.6 million SIF grant

Pfizer announces unrestricted access to patient assessment aids for mental disorders

AIDS 2010 studies, releases: Criminalization, discrimination of high-risk groups; Test-and-treat; UNAIDS launches HIV prevention commission

AIDS 2010: Halving HIV/TB co-infection deaths; Financial transaction tax discussed, and more

New HIV drug on the block

Tibotec reports Phase 3 trial results of TMC278 vs. EFV in treatment-naive HIV-1-infected adults

Towards a cure: HIV reservoirs and strategies to control them

AHF calls upon Congress to immediately pass 'HIV/AIDS Saves Lives First Act of 2010'

AHF hosts 'Test & Treat: Getting to 10 Million on ARVs' satellite session

Correlates of HIV stigma in HIV-positive women: Study

Adult circumcision proposed for possible HIV prevention in gay men

New era of scientific innovation to drive novel ways of treating, preventing HIV

Childhood experiences, psychosocial health problems increase risk of HIV in bisexual men

Current myths vs. realities in global AIDS funding

Study marks significant milestone for microbicide research field, HIV prevention

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News